TRIumph:

Viacheslav Muratov1, Karolina Jagiello1,2, Tomasz Puzyn1,2

  • 1University of Gdansk, Faculty of Chemistry, Laboratory of Environmental Chemoinformatics, Wita Stwosza 63, 80-308 Gdansk, Poland. karolina.jagiello@ug.edu.pl.

Nanoscale horizons
|September 3, 2025
PubMed
まとめ

複合的な遺伝子発現データを単一の変数に簡素化する新型トランスクリプトミック応答指数 (TRI) が開発されました. このTRIは,多壁の炭素ナノチューブ特性とリンクし,正確な予測を可能にし,計算の必要性を軽減します.

関連する概念動画

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...